Assured supply over price
- Procurement commentary argued that sourcing should prioritise assured supply instead of selecting the lowest price, especially for healthcare buyers. - Roy Lilley urged UK/allied sourcing and greater transparency to build resilience in health procurement. - The thread reflects growing emphasis on supply continuity and transparency after recent global disruptions (x.com).
Healthcare buyers are being pushed to treat assured supply as a core test in tenders, not an afterthought behind the lowest bid. (myemail.constantcontact.com) That argument was set out this week by NHS commentator Roy Lilley, who said procurement should buy “not just lowest-price, but assured-supply” and should look harder at United Kingdom or allied manufacturing, origin data and surge capacity. (myemail.constantcontact.com) The point lands in a system that still buys huge volumes centrally. Parliament’s Public Accounts Committee said in a March 27, 2024 report that the National Health Service in England spends about £8 billion a year on medical equipment and consumables, and that NHS Supply Chain was covering about 57% of that market against a 62% target. (publications.parliament.uk) The same committee said NHS Supply Chain was created to aggregate buying power and cut price variation, but trusts still spent about £3.4 billion a year outside the system. It said wider use of existing contracts could save another £60 million to £90 million by 2026. (publications.parliament.uk) Since 2022, NHS Supply Chain has run a dedicated resilience team focused on supply disruptions, stock policy, supplier management and product risk. The team says it is piloting stronger safeguards for “highly critical products” and building more visibility into upstream supply chains and product alternatives. (supplychain.nhs.uk) The policy backdrop has also shifted toward disclosure. The Procurement Act 2023 took effect on February 24, 2025, and NHS Shared Business Services said it added a central digital platform, new notice requirements and annual reporting of key performance indicators on contracts above £5 million. (sbs.nhs.uk) The Department of Health and Social Care and NHS England made medicines resilience a public priority in an August 11, 2025 policy paper. They said the aim was to reduce shortages, limit harm to patients and give “greater transparency” about how government and the health service are responding. (gov.uk) That language follows years of official reviews shaped by the pandemic. The United Kingdom Covid-19 Inquiry opened its procurement module on October 24, 2023 to examine how the four nations bought and distributed personal protective equipment, ventilators and oxygen. (covid19.public-inquiry.uk) Government strategy documents now use similar terms for medical devices. The Medical Technology Strategy says continuity of supply should be “at the forefront” of sourcing, production and supply-chain models, especially for the most critical technologies. (gov.uk) The practical question is no longer only what a hospital glove, syringe or implant costs on award day. It is whether the supplier can still deliver when shipping routes snarl, factories stop or demand spikes. (supplychain.nhs.uk)
